Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design
Lidia Ciccone, Nicolò Tonali, Susanna Nencetti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 1145-1162
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111906-111906
Open Access | Times Cited: 60
The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
Lidia Ciccone, Chenghui Shi, Davide Di Lorenzo, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2439-2439
Open Access | Times Cited: 57
The impact of glutathione metabolism in autism spectrum disorder
Geir Bjørklund, Monica Daniela Doşa, Michaël Maes, et al.
Pharmacological Research (2021) Vol. 166, pp. 105437-105437
Closed Access | Times Cited: 51
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism
Chiara Sanguinetti, Marianna Minniti, Vanessa Susini, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1906-1906
Open Access | Times Cited: 34
Transthyretin: Its function and amyloid formation
Mitsuharu Ueda
Neurochemistry International (2022) Vol. 155, pp. 105313-105313
Open Access | Times Cited: 29
Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
Lidia Ciccone, Jennifer Vandooren, Susanna Nencetti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 86-86
Open Access | Times Cited: 33
Molecular Mechanisms of Inhibition of Protein Amyloid Fibril Formation: Evidence and Perspectives Based on Kinetic Models
Igor A. Sedov, Diliara Khaibrakhmanova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13428-13428
Open Access | Times Cited: 26
Special Issue “Advances in Drug Discovery and Synthesis”
Lidia Ciccone, Susanna Nencetti
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 584-584
Open Access
Evaluation of Polyphenol Content and Antioxidant Capacity of Aqueous Extracts from Eight Medicinal Plants from Reunion Island: Protection against Oxidative Stress in Red Blood Cells and Preadipocytes
Éloïse Checkouri, Franck Reignier, Christine Robert‐Da Silva, et al.
Antioxidants (2020) Vol. 9, Iss. 10, pp. 959-959
Open Access | Times Cited: 32
Antioxidant activity of calycosin against α-synuclein amyloid fibrils-induced oxidative stress in neural-like cells as a model of preventive care studies in Parkinson's disease
Qichen Pan, Yunchao Ban, Suliman Khan
International Journal of Biological Macromolecules (2021) Vol. 182, pp. 91-97
Closed Access | Times Cited: 25
Transthyretin Amyloidosis: Role of oxidative stress and the beneficial implications of antioxidants and nutraceutical supplementation
Fredrick Nwude Eze
Neurochemistry International (2024) Vol. 179, pp. 105837-105837
Closed Access | Times Cited: 3
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease?
Federica Saponaro, Jin Hae Kim, Grazia Chiellini
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8672-8672
Open Access | Times Cited: 24
Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological induction
Elisabetta Orlandini, Lidia Ciccone, Susanna Nencetti, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 12, pp. 2353-2353
Open Access | Times Cited: 23
The Function of Transthyretin Complexes with Metallothionein in Alzheimer’s Disease
Natalia Zaręba, Marta Kepinská
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9003-9003
Open Access | Times Cited: 21
Preparation of pumpkin oil-based nanoemulsion as a potential estrogen replacement therapy to alleviate neural-immune interactions in an experimental postmenopausal model
Mona A. El‐Bana, Sherien M. El‐Daly, Enayat A. Omara, et al.
Prostaglandins & Other Lipid Mediators (2023) Vol. 166, pp. 106730-106730
Closed Access | Times Cited: 7
The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer’s Disease
Anita Domańska, Arkadiusz Orzechowski, Anna Litwiniuk, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 16
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship
Suchitra Nishal, Parmita Phaugat, Jyoti Bazaad, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 1057-1069
Closed Access | Times Cited: 11
Cyclic-NDGA Effectively Inhibits Human γ-Synuclein Fibrillation, Forms Nontoxic Off-Pathway Species, and Disintegrates Preformed Mature Fibrils
Sneh Lata Singh, Rajiv Bhat
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1770-1786
Closed Access | Times Cited: 2
Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs
Lidia Ciccone, Nicolò Tonali, Susanna Nencetti, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 8, pp. 1554-1554
Open Access | Times Cited: 14
Physiological Metals Can Induce Conformational Changes in Transthyretin Structure: Neuroprotection or Misfolding Induction?
Lidia Ciccone, Nicolò Tonali, William Shepard, et al.
Crystals (2021) Vol. 11, Iss. 4, pp. 354-354
Open Access | Times Cited: 13
Deep blue autofluorescence reflects the oxidation state of human transthyretin
Elżbieta Wieczorek, Zofia Wygralak, Sylwia Kędracka‐Krok, et al.
Redox Biology (2022) Vol. 56, pp. 102434-102434
Open Access | Times Cited: 9
Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis
Mineyuki Mizuguchi, Yusuke Nakagawa, Kishin Inui, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16218-16233
Closed Access | Times Cited: 8
Neuroprotective effect against amyloidogenic transthyretin aggregates - induced cytotoxicity on human neuroblastoma cell by phenolic-rich Centella asiatica extract
Fredrick Nwude Eze, Apinna Bunyapongpan, Porntip Prapunpoj
Heliyon (2024) Vol. 10, Iss. 20, pp. e39159-e39159
Closed Access | Times Cited: 1
Monoaryl derivatives as transthyretin fibril formation inhibitors: Design, synthesis, biological evaluation and structural analysis
Lidia Ciccone, Susanna Nencetti, Nicolò Tonali, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 18, pp. 115673-115673
Closed Access | Times Cited: 11
Computational anti-COVID-19 drug design: progress and challenges
Jinxian Wang, Ying Zhang, Wenjuan Nie, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top